Dipyridamole stress and rest gated 99mTc-sestamibi myocardial perfusion spect: Left ventricular function indices and myocardial perfusion findings

Iranian Journal of Nuclear Medicine

Volumn 15, Issue 27, 2007, Pages 1-7

  Kakhki, Vahid Reza Dabbagh ^a   Jabari, Hadi ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dipyridamole; Ejection fraction; Gated SPECT; Left ventricular volume; Stunning

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE STEADY POTENTIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLE;

EID: 34547122203     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computer tomographic imaging. J Am Coll Cardiol. 1997; 30:1687-92.
2. Wackers FJT. Myocardial Perfusion Imaging. In: Sandler MP, Coleman RE, Patton JA, Wackers FJT, Gottschalk A. Diagnostic Nuclear Medicine. 4th ed. Philadelphia, Lippincott Williams & Wilkins, 2003: 273-317.
3. 99mTc-MIBI SPECT: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2004; 31:482-490.
4. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 1995; 36:952-5.
5. Sharir T, Germano G, Kanavagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999; 100:1035-42.
6. Lee KL, Pryor DB, Pieper KS, Harrell Jr. FE, Califf RM, Mark DB, et al. The prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. Circulation. 1990; 82:1705-171.
7. Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Germano G. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol. 1997; 30:1641-1648.
8. Borges-Neto S, Javaid A, Shaw LK, Kong DF, Hanson MW, Pagnanelli RA, et al. Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same day perfusion-function protocol. Radiology. 2000; 215:529-533.
9. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation. 1982;66: 1146-1149.
10. Hale SL, Kloner RA. Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts. J Cardiovasc Pharmacol Ther. 2005; 10: 121-129.
11. Mut F, Beretta M, Vidal I, Rener A, Alonso O, Nunez M, et al. Identification of myocardial stunning by means of gated perfusion SPECT in patients undergoing ischaemic stress myocardial tests. World J Nucl Med. 2003; 2; 122-125.
12. Dakik HA, Alam S. Myocardial stunning induced and detected by adenosine stress perfusion imaging. J Nucl Cardiol. 2001; 8:711-712.
13. Giubbini R, Rossini P, Bertagna F, Bosio G, Paghera B, Pizzocaro C, et al. Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary bypass grafting. Eur J Nucl Med Mol Imaging. 2004; 31:1371-7.
14. Kloner RA. Myocardial Stunning. Lancet. 1993; 341:1323-1325.
15. Rinaldi CA, Hall RJ. Myocardial stunning and hibernation in clinical practice. In J Clin Pract. 2000; 54:659-664.
16. Ambrosio G, Tritto I. Clinical manifestation of myocardial stunning. Coron Artery Dis. 2001; 12: 357-361.
17. Barnes E, Dutka DP, Khan M, Camici PG, Hall RJ. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol.2002; 282: H1603-1608.
18. Otto AC, van Staden J, van Aardt A, van Aswegen E, Joubert G, Englebrecht H. Evaluation of exercise-induced stunning using myocardial perfusion imaging. Cardiovasc J S Afr. 2001; 12:259-262.
19. Beretta M, Rener A, Vidal I, Nunez M, Alvarez B, Mut F. Demonstration of myocardial stunning after dipyridamole stress test with gated perfusion SPECT. J Nucl Cardiol. 2001; 8: S70.
20. Lee DS, Yeo JS, Chung JK, Lee MM, Lee MC. Transient prolonged stunning induced by dipyridamole and shown on 1- and 24-hour poststress 99mTc-MIBI gated SPECT. J Nucl Med. 2000;41: 27-35.
21. Paeng JC, Lee DS, Yeo JS, Noh CI, Kim YK, Chung JK, et al. Septal stunning by dipyridamole stress shown on quantitative gated perfusion SPECT in a child with hypertrophic cardiomyopathy. Clin Nucl Med. 2002; 27: 96-100.
22. Ben-Haim S,Gips S, Merdler A, Front A, Tamir A. Myocardial stunning demonstrated with rest and post-stress measurements of left ventricular function using dual-isotope gated myocardial perfusion SPECT. Nucl Med Commun. 2004; 25: 657-663.
23. Weinmann P, Moretti J-L. Effects of dipyridamole on left ventricular function. J Nucl Cardiol. 2000; 7:103-106.
24. Songy B, Finker F, Gray M. Postdipyridamole myocardial stunning assessed by gated sestamibi myocardial perfusion SPECT [Abstract]. J Nucl Med. 2002; 43:190P.
25. Santiago JF, Heiba SI, Jana S, Mirzaitehrane M, Dede F, Abdel-Dayem HM. Transient ischemic stunning of the myocardium in stress thallium-201 gated SPET myocardial perfusion imaging: segmental analysis of myocardial perfusion, wall motion and wall thickening changes. Eur J Nucl Med Mol Imaging. 2002; 29:979-983.
26. Hashimoto J, Kubo A, Iwasaki R, Iwanaga S, Mitamura H, Ogawa S, et al. Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise. Eur J Nucl Med. 1999; 12: 1541-1546.
27. Bestteti A, Dileo C, Alessi A, Triulzi A, Taglibue L, Tarolo GL. Post-stress end-systolic dilation: a marker of endocardial post-ischemic stunning. Nucl Med Commun. 2001;22: 685-693.
28. Kakhki VD, Zakavi SR, Sadeghi R, Yousefi A. Importance of gated imaging in both phases of myocardial perfusion SPECT: Myocardial stunning after dipyridamole infusion. J Nucl Med Technol. 2006;34:88-91
29. Hung GU, Chen CP, Yang KT. Incremental value of ischemic stunning on the detection of severe and extensive coronary artery disease in dipyridamole Tl-201 gated myocardial perfusion imaging. Int J Cardiol.2005; 105:108-110.